FAST vs KPTI · P/E 43, rev $4.59B vs rev $68.5M
Fastenal Company (FAST) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the FAST and KPTI stock pages for the full models.
Not investment advice.